Bulletin
Investor Alert

INmune Bio Inc.

NAS: INMB

GO
/marketstate/country/us

After Hours

/zigman2/quotes/206182062/composite

$

8.78

Change

0.00 0.00%

Volume

Volume 295

Jan 21, 2022, 4:00 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/206182062/composite

Previous close

$ 8.85

$ 8.78

Change

-0.07 -0.79%

Day low

Day high

$8.45

$9.07

Open
Open: 8.79

52 week low

52 week high

$8.16

$30.37

Open

Market cap

$156.66M

Average volume

215,193

P/E ratio

N/A

Rev. per Employee

$5,783

EPS

-1.55

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/inmb

MarketWatch News on INMB

  1. Robinhood investors are propping up this stock market, says JPMorgan

    8:33 a.m. Sept. 2, 2021

    - Barbara Kollmeyer

  2. Analyst Raises Price Targets on 3 Smaller Alzheimer's Stocks

    10:50 a.m. July 7, 2021

    - Barron's Online

  3. INmune Bio stock price target raised to $42 from $32 at Maxim Group

    7:31 a.m. July 7, 2021

    - Tomi Kilgore

  4. INmune Bio started at buy with $29 stock price target at B. Riley

    6:23 a.m. April 21, 2021

    - Tomi Kilgore

  5. INmune Bio stock price target raised to $32 from $16 at Maxim Group

    7:39 a.m. Jan. 22, 2021

    - Tomi Kilgore

  6. INmune Bios started at buy with $13 stock price target at Maxim Group

    6:38 a.m. March 19, 2019

    - Tomi Kilgore

/news/nonmarketwatch/company/us/inmb

Other News on INMB

  1. INmune Bio, The Biotech In My Stable For After Cassava Sciences

    11:23 a.m. Jan. 17, 2022

    - Seeking Alpha

  2. Warning: INMB is at high risk of performing badly

    4:21 a.m. Dec. 15, 2021

    - Seeking Alpha

  3. Warning: INMB is at high risk of performing badly

    4:25 a.m. Dec. 3, 2021

    - Seeking Alpha

  4. INmune Bio, Inc. (INMB) Q3 2021 Earnings Call Transcript

    2:01 a.m. Nov. 4, 2021

    - Motley Fool

  5. INmune Bio EPS misses by $0.19

    3:36 p.m. Nov. 3, 2021

    - Seeking Alpha

  6. 10-Q: INMUNE BIO, INC.

    3:14 p.m. Nov. 3, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  7. Notable earnings after Wednesday's close

    4:35 p.m. Nov. 2, 2021

    - Seeking Alpha

  8. INmune Bio A No-Brainer Investment

    4:44 p.m. Oct. 13, 2021

    - Seeking Alpha

  9. GSAT, ATER and PXLW among mid-day movers

    12:29 p.m. Sept. 8, 2021

    - Seeking Alpha

  10. INmune slides 20% following 192.5K share offering from Xencor

    11:46 a.m. Sept. 8, 2021

    - Seeking Alpha

  11. INmune (INMB) Announces Positive Data for its AD Candidate

    10:33 a.m. Sept. 2, 2021

    - Zacks.com

  12. DQ, BTBT and GOTU among pre market gainers

    7:34 a.m. Sept. 2, 2021

    - Seeking Alpha

  13. INmune Bio jumps 11% after XPro data in Alzheimer’s disease

    6:17 a.m. Sept. 2, 2021

    - Seeking Alpha

  14. Loading more headlines...
/news/pressrelease/company/us/inmb

Press Releases on INMB

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.